Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ke-Qing Shi

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Cancer Cell International|March 1, 2019
Expression of the Wnt ligands gene family and its relationship to prognosis in hepatocellular carcinomaJia-Jia Dong, Li Ying, Ke-Qing Shi
BMJ (Clinical Research Ed.)|August 31, 2015
Skin lesion in a critically ill manMing-Hua Zheng, Ke-Qing Shi, Yong-Ping Chen
Liver International : Official Journal of the International Association for the Study of the Liver|November 2, 2016
Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in HCV genotype IV infected patientsBin-Qiao Wang, Yong-Lin Wang, Ke-Qing Shi
Liver International : Official Journal of the International Association for the Study of the Liver|October 30, 2016
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patientsBin-Qiao Wang, Yong-Lin Wang, Ke-Qing Shi
Hepatology (Baltimore, Md.)|March 5, 2011
Meta-analysis using individual participant data is the gold standard for diagnostic studiesMing-Hua Zheng, Ke-Qing Shi, Yu-Chen Fan, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 18, 2014
Association between a polymorphism in miR-34b/c and susceptibility to cancer--a meta-analysisZhuo Lin, Li Chen, Mei Song, et al.
Hepatology (Baltimore, Md.)|April 8, 2011
Methodological quality assessment for traditional Chinese medicine: CONSORT is betterMing-Hua Zheng, Yu-Chen Fan, Ke-Qing Shi, et al.
Digestive Diseases and Sciences|February 28, 2012
Performance of platelet count/spleen diameter ratio for diagnosis of esophageal varices in cirrhosis: a meta-analysisLi Ying, Xiao Lin, Zuo-Liu Xie, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 19, 2013
A new strategy for treatment of liver fibrosis: letting MicroRNAs do the jobShao-Long Chen, Ming-Hua Zheng, Ke-Qing Shi, et al.
Clinical Therapeutics|May 4, 2010
A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patientsMing-Hua Zheng, Ke-Qing Shi, Zhi-Juan Dai, et al.
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Cancer Cell International|March 1, 2019
Expression of the Wnt ligands gene family and its relationship to prognosis in hepatocellular carcinomaJia-Jia Dong, Li Ying, Ke-Qing Shi
BMJ (Clinical Research Ed.)|August 31, 2015
Skin lesion in a critically ill manMing-Hua Zheng, Ke-Qing Shi, Yong-Ping Chen
Liver International : Official Journal of the International Association for the Study of the Liver|November 2, 2016
Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in HCV genotype IV infected patientsBin-Qiao Wang, Yong-Lin Wang, Ke-Qing Shi
Liver International : Official Journal of the International Association for the Study of the Liver|October 30, 2016
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patientsBin-Qiao Wang, Yong-Lin Wang, Ke-Qing Shi
Hepatology (Baltimore, Md.)|March 5, 2011
Meta-analysis using individual participant data is the gold standard for diagnostic studiesMing-Hua Zheng, Ke-Qing Shi, Yu-Chen Fan, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 18, 2014
Association between a polymorphism in miR-34b/c and susceptibility to cancer--a meta-analysisZhuo Lin, Li Chen, Mei Song, et al.
Hepatology (Baltimore, Md.)|April 8, 2011
Methodological quality assessment for traditional Chinese medicine: CONSORT is betterMing-Hua Zheng, Yu-Chen Fan, Ke-Qing Shi, et al.
Digestive Diseases and Sciences|February 28, 2012
Performance of platelet count/spleen diameter ratio for diagnosis of esophageal varices in cirrhosis: a meta-analysisLi Ying, Xiao Lin, Zuo-Liu Xie, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 19, 2013
A new strategy for treatment of liver fibrosis: letting MicroRNAs do the jobShao-Long Chen, Ming-Hua Zheng, Ke-Qing Shi, et al.
Clinical Therapeutics|May 4, 2010
A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patientsMing-Hua Zheng, Ke-Qing Shi, Zhi-Juan Dai, et al.
Pageof 9